These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29635144)

  • 1. Bladder cancer survival: Women better off in the long run.
    Andreassen BK; Grimsrud TK; Haug ES
    Eur J Cancer; 2018 May; 95():52-58. PubMed ID: 29635144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder cancer survival: Women only fare worse in the first two years after diagnosis.
    Richters A; Dickman PW; Witjes JA; Boormans JL; Kiemeney LALM; Aben KKH
    Urol Oncol; 2019 Dec; 37(12):853-861. PubMed ID: 31481299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Urothelial Bladder Cancer Survival.
    Radkiewicz C; Edgren G; Johansson ALV; Jahnson S; Häggström C; Akre O; Lambe M; Dickman PW
    Clin Genitourin Cancer; 2020 Feb; 18(1):26-34.e6. PubMed ID: 31787542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014.
    Andreassen BK; Aagnes B; Gislefoss R; Andreassen M; Wahlqvist R
    BMC Cancer; 2016 Oct; 16(1):799. PubMed ID: 27737647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crude mortality and loss of life expectancy of patients diagnosed with urothelial carcinoma of the urinary bladder in Norway.
    Andreassen BK; Myklebust TÅ; Haug ES
    Scand J Urol; 2017 Feb; 51(1):38-43. PubMed ID: 28084860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sex difference on survival of bladder cancer: A population-based registry data in Japan.
    Nakayama M; Ito Y; Hatano K; Nakai Y; Kakimoto KI; Miyashiro I; Nishimura K
    Int J Urol; 2019 Jun; 26(6):649-654. PubMed ID: 30916420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer.
    Thorstenson A; Hagberg O; Ljungberg B; Liedberg F; Jancke G; Holmäng S; Malmström PU; Hosseini A; Jahnson S
    Scand J Urol; 2016 Aug; 50(4):292-7. PubMed ID: 27002743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-specific survival by stage of bladder cancer and factors collected by Mallorca Cancer Registry associated to survival.
    Ripoll J; Ramos M; Montaño J; Pons J; Ameijide A; Franch P
    BMC Cancer; 2021 Jun; 21(1):676. PubMed ID: 34098901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
    J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.
    Jahnson S; Hosseini Aliabad A; Holmäng S; Jancke G; Liedberg F; Ljungberg B; Malmström PU; Rosell J
    Scand J Urol; 2016; 50(1):14-20. PubMed ID: 26382667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
    Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W
    Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.
    Raitanen MP; Nieminen P; Tammela TL
    Br J Urol; 1995 Oct; 76(4):470-4. PubMed ID: 7551884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder.
    Golabesk T; Palou J; Rodriguez O; Parada R; Skrobot S; Peña JA; Villavicencio H
    Urology; 2017 Feb; 100():145-150. PubMed ID: 27765584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
    Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Klint A; Bray F; Storm HH
    Acta Oncol; 2010 Jun; 49(5):655-64. PubMed ID: 20156116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.